Clinical Trial Update: Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan plus temozolomide in patients with breast cancer who previously had brain metastases. Results from the study have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Temodar (Temozolomide)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-04-20